the impact of the fda's recent shift on covid ldts and beyond
Published 2 years ago • 240 plays • Length 46:52Download video MP4
Download video MP3
Similar videos
-
12:11
covid-19 lab-developed tests: the fda's evolving approach
-
50:55
asymptomatic covid-19 testing - requirements & the change in fda regulatory authority over ldts
-
8:42
covid-19 lab developed tests policy reversal: how did we get here?
-
2:49
the impacts of the fda's policy update on lab-developed tests
-
4:26
with valid act stalled, should the fda regulate laboratory-developed tests?
-
3:56
the future of the medical lab: what will post-covid testing look like?
-
1:01:43
what the fda's final rule means for the future of laboratory developed tests
-
38:23
covid testing is evolving - new insights for clinical labs
-
4:20
what are the current fda guidelines for monkeypox testing?
-
3:22
how labs should prepare for new laboratory developed test rules and what comes next
-
39:03
surveillance and screening testing for covid-19: the next step your lab needs to take
-
1:00:21
the impact of the covid-19 pandemic on laboratory and testing practices
-
45:47
innovative advancements in covid testing
-
20:35
explaining neutralizing antibodies & covid titers
-
5:08
fda regulation of diagnostic testing and covid-19
-
2:18
lighthouse lab | swab journey
-
55:32
preparing your clinical lab or pathology practice for post-covid success
-
1:01:08
unpacking the fda's new proposed rule for laboratory developed tests
-
23:27
the importance of laboratory developed tests in diagnosing covid-19